Cadwalader Aids AngioDynamics In $372M Device Maker Buy

Law360, New York (January 31, 2012, 12:39 PM EST) -- Private equity firm Avista Capital Partners has agreed to sell medical device maker Navilyst Medical to AngioDynamics Inc. for $372 million in cash and stock, the companies announced Tuesday.

New York-based AngioDynamics said it would fund the transaction, based on Monday's per-share closing price of $14.20, with approximately $97 million in cash on hand and $150 million from a fully committed bank financing facility of debt and new common stock from JPMorgan Chase & Co, Bank of America NA and KeyBank National Association, which is owned...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.